Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas A Abrams

Showing results (1-10 of 48) with videos related to

Pageof 5
Sort By:
Current Oncology Reports|January 27, 2007
Targeted therapy for dermatofibrosarcoma protuberansThomas A Abrams, Scott M Schuetze
Journal of the National Cancer Institute|February 11, 2014
Chemotherapy usage patterns in a US-wide cohort of patients with metastatic colorectal cancerThomas A Abrams, Gary Meyer, Deborah Schrag, et al.
The Oncologist|May 7, 2017
Patterns of Chemotherapy Use in a U.S.-Based Cohort of Patients with Metastatic Pancreatic CancerThomas A Abrams, Gary Meyer, Jeffrey A Meyerhardt, et al.
Abdominal Radiology (New York)|March 18, 2023
Can MRI features predict clinically relevant hepatocellular carcinoma genetic subtypes?Xiaoyang Liu, Yang Guo, Lei Zhao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 20, 2011
Patterns of adjuvant chemotherapy use in a population-based cohort of patients with resected stage II or III colon cancerThomas A Abrams, Rick Brightly, Jianbin Mao, et al.
Digestive Diseases and Sciences|July 23, 2021
Priming of Sorafenib Prior to Radiofrequency Ablation Does Not Increase Treatment Effect in Hepatocellular CarcinomaBruno Bockorny, Andrea J Bullock, Thomas A Abrams, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 31, 2013
First-in-man phase I study of GC33, a novel recombinant humanized antibody against glypican-3, in patients with advanced hepatocellular carcinomaAndrew X Zhu, Philip J Gold, Anthony B El-Khoueiry, et al.
Cancer Chemotherapy and Pharmacology|October 21, 2010
A prospective phase II study of 2-methoxyestradiol administered in combination with bevacizumab in patients with metastatic carcinoid tumorsMatthew H Kulke, Jennifer A Chan, Jeffrey A Meyerhardt, et al.
Endocrine-Related Cancer|June 28, 2012
Phase I study of pasireotide (SOM 230) and everolimus (RAD001) in advanced neuroendocrine tumorsJennifer A Chan, David P Ryan, Andrew X Zhu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 15, 2014
Identification of potentially avoidable hospitalizations in patients with GI cancerGabriel A Brooks, Thomas A Abrams, Jeffrey A Meyerhardt, et al.
Pageof 5

Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
Current Oncology Reports|January 27, 2007
Targeted therapy for dermatofibrosarcoma protuberansThomas A Abrams, Scott M Schuetze
Journal of the National Cancer Institute|February 11, 2014
Chemotherapy usage patterns in a US-wide cohort of patients with metastatic colorectal cancerThomas A Abrams, Gary Meyer, Deborah Schrag, et al.
The Oncologist|May 7, 2017
Patterns of Chemotherapy Use in a U.S.-Based Cohort of Patients with Metastatic Pancreatic CancerThomas A Abrams, Gary Meyer, Jeffrey A Meyerhardt, et al.
Abdominal Radiology (New York)|March 18, 2023
Can MRI features predict clinically relevant hepatocellular carcinoma genetic subtypes?Xiaoyang Liu, Yang Guo, Lei Zhao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 20, 2011
Patterns of adjuvant chemotherapy use in a population-based cohort of patients with resected stage II or III colon cancerThomas A Abrams, Rick Brightly, Jianbin Mao, et al.
Digestive Diseases and Sciences|July 23, 2021
Priming of Sorafenib Prior to Radiofrequency Ablation Does Not Increase Treatment Effect in Hepatocellular CarcinomaBruno Bockorny, Andrea J Bullock, Thomas A Abrams, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 31, 2013
First-in-man phase I study of GC33, a novel recombinant humanized antibody against glypican-3, in patients with advanced hepatocellular carcinomaAndrew X Zhu, Philip J Gold, Anthony B El-Khoueiry, et al.
Cancer Chemotherapy and Pharmacology|October 21, 2010
A prospective phase II study of 2-methoxyestradiol administered in combination with bevacizumab in patients with metastatic carcinoid tumorsMatthew H Kulke, Jennifer A Chan, Jeffrey A Meyerhardt, et al.
Endocrine-Related Cancer|June 28, 2012
Phase I study of pasireotide (SOM 230) and everolimus (RAD001) in advanced neuroendocrine tumorsJennifer A Chan, David P Ryan, Andrew X Zhu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 15, 2014
Identification of potentially avoidable hospitalizations in patients with GI cancerGabriel A Brooks, Thomas A Abrams, Jeffrey A Meyerhardt, et al.
Pageof 5